510(k) K192774
K192774 is an FDA 510(k) premarket notification submitted by Biocardia for the device "BioCardia 8F Morph DNA Deflectable Guide Catheter". The FDA issued a decision of Substantially Equivalent on January 7, 2020. The device falls under product code DQY (Catheter, Percutaneous), a Class II device regulated under 21 CFR 870.1250. Biocardia has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 7, 2020
- Date Received
- September 30, 2019
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheter, Percutaneous
- Device Class
- Class II
- Regulation Number
- 870.1250
- Review Panel
- CV
- Submission Type